Sub Banner Image

Is Vertex Pharmaceuticals Stock Underperforming the S&P 500?

Equities

Kritika Sarmah

·

September 8, 2025

·

Barchart

Vertex Pharmaceuticals has lagged the broader S&P 500 Index over the past year, but Wall Street analysts remain moderately optimistic about the company’s long-term prospects.

More from

Barchart

More

Equities

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.